123ArticleOnline Logo
Welcome to 123ArticleOnline.com!
ALL >> Business >> View Article

Narcolepsy Drugs Market Significant Growth, Latest Trends, Opportunity And Forecast 2032 Report

Profile Picture
By Author: Ellenkuhn
Total Articles: 5
Comment this article
Facebook ShareTwitter ShareGoogle+ ShareTwitter Share

According to a new report published by K D Market Insights, titled, “Narcolepsy Drugs Market Insights, Trends, Opportunity & Forecast, 2023–2032,” the global narcolepsy drugs market size is anticipated to witness moderate growth during the forecast period i.e., 2023-2032. The rising prevalence of narcolepsy, a chronic sleep disorder characterized by excessive daytime sleepiness and sudden episodes of sleep increasing awareness about narcolepsy, advancements in drug therapies, and the growing emphasis on improving the quality of life for affected individuals which are the major factors augmenting the growth of the global narcolepsy drugs market.
The aging population and their vulnerability to various chronic and acute diseases that require medical care. The rise in narcoleptic diseases, changing lifestyles, and the increase in stress levels, which can contribute to the development of narcolepsy disorders are further expected to create ample growth opportunities for the global narcolepsy drugs market during the forecast period i.e., 2023-2032. Moreover, advancements in medical research and development have led ...
... to the introduction of innovative and effective treatment options has propelled market expansion. Reimbursement policies incentivize patients to seek appropriate treatment, is expected to contribute towards the market growth during the period.
The North America region accounted for the largest share in the global narcolepsy drugs market in 2022. The region is further projected to continue dominating in the market and also register the highest CAGR in the market during the forecast period. This can be attributed to the high prevalence of narcolepsy and the presence of well-established healthcare infrastructure.
According to disease type, the excessive daytime sleepiness segment accounted for the largest market share in the narcolepsy drugs market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
The global narcolepsy drugs market is segmented into disease type, therapeutics type and region. Based on disease type, the market is bifurcated into daytime extreme sleepiness, cataplexia, and other disease type. Based on therapeutics type, it is classified into central nervous system stimulants, tricyclic antidepressants, sodium oxybate, selective serotonin reuptake inhibitor, and other therapeutic type.
The global narcolepsy drugs market is analyzed across North America (U.S. & Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East & Africa).
Key Insights of Narcolepsy drugs Market
• On the basis of disease type, the excessive daytime sleepiness segment accounted for the largest market share in the narcolepsy drugs market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
• On the basis of region, North America accounted for the largest share in the global narcolepsy drugs market in 2022. The region is further projected to continue dominating in the market during the forecast period.
• On the basis of region, Asia-Pacific is estimated to account for the second largest share in the market during the forecast period.
Some of the major narcolepsy drugs companies profiled in the report include Teva pharmaceutical industries ltd., Takeda pharmaceutical company, Bioprojet pharma Sarl, jazz pharmaceutical plc, arena pharmaceutical, inc., Novartis international ag, Shinogi inc., and ligand pharmaceuticals incorporated.

Total Views: 373Word Count: 554See All articles From Author

Add Comment

Business Articles

1. Finding Your Next Book: A Reader’s Guide To Om Books International
Author: CONTENT EDITOR FOR SAMPHIRE IT SOLUTIONS PVT LTD

2. A Complete Guide To Starting A Business In A Uae Free Zone
Author: Eden counsel

3. What Makes Hardcover Book Printing Different From Paperback Printing?
Author: Steve Morgan

4. What To Do If A Dog Charges: Step-by-step Safety Tips For Field Workers
Author: andy

5. Expansion Joint Manufacturer: Choosing Durable Bridge Expansion Joint Solutions
Author: Phani

6. Mens Shoes Product Data Api India For Market Insights
Author: Actowiz Solution

7. Study Mbbs In Philippines 2026–27: Admission, Course Duration, Fees, And Career Opportunities
Author: Mbbs Blog

8. Iso 9001 Certification In Tamil Nadu
Author: sqccertification

9. Medical Universities, Fees, Eligibility, Admission Process & Scholarships For Indian Students!
Author: Mbbs Blog

10. How To Choose The Perfect Curtains For A Stylish And Comfortable Home
Author: GVK Home Decors

11. An Ideal Destination To Study Mbbs Is Georgia
Author: Mbbs Blog

12. Trusted Construction And Industrial Scrap Buyers In Hyderabad For Best Scrap Value
Author: tradebinscrap

13. Textile Shops In Trichy
Author: Massclick

14. Best Electronic Scrap Buyers In Hyderabad – Reliable Ac Scrap And Old Ac Scrap Buying Services
Author: tradebinscrap

15. Isaca Reaches 200,000 Members Advancing Digital Trust And Ai Governance
Author: Madhulina

Login To Account
Login Email:
Password:
Forgot Password?
New User?
Sign Up Newsletter
Email Address: